Skip to main content

Advertisement

SpringerLink
Log in

Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

LYVE-1, a specific marker of lymphatics, is expressed in hepatic sinusoidal endothelium. A previous study revealed that LYVE-1 expression in sinusoidal endothelium was reduced in cirrhosis. However, it is still obscure how LYVE-1 expression in sinusoidal endothelium was reduced during the disease progression. To elucidate whether there were relationships among LYVE-1 attenuation, sinusoidal capillarization, and disease progression, we performed immunohistochemical investigations based on frozen human livers.

Methods

Frozen liver sections of chronic hepatitis (n = 8), cirrhosis (n = 13), and normal/control liver (n = 10) were examined by immunostaining for lymphatic endothelial markers (LYVE-1 and D2-40) and vascular endothelial markers (CD31 and von Willebrand factor). Computer-aided morphometry was applied to obtain objective data. The diseased liver tissues were also examined ultrastructurally.

Results

In controls, sinusoidal endothelium was positive for LYVE-1 and CD31, but negative for D2-40 and von Willebrand factor. In chronic hepatitis and cirrhosis, LYVE-1 expression in sinusoidal endothelium was attenuated, especially in areas adjacent to active inflammatory or fibrotic lesions, while von Willebrand factor was reciprocally expressed in sinusoidal endothelium. The morphometric analyses revealed that LYVE-1 positivity in sinusoidal endothelium was significantly (P < 0.0001) decreased in chronic hepatitis and cirrhosis compared to controls and was negatively correlated (Rs = −0.72, P < 0.0001) to von Willebrand factor positivity. Furthermore, LYVE-1 positivity was negatively correlated to inflammatory grade (Rs = −0.51, P = 0.021) and fibrosis severity (Rs = −0.46, P = 0.038). Sinusoidal endothelium in the diseased livers showing LYVE-1 attenuation had lost fenestrations.

Conclusions

These findings indicated that LYVE-1 attenuation in sinusoidal endothelium was one of the manifestations of capillarization, and was associated with hepatic disease progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Wisse E, De Zanger RB, Charels K, Van Der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology. 1985;5:683–92.

    Article  CAS  PubMed  Google Scholar 

  2. Enzan H, Hara H, Yamashita Y, Ohkita T, Yamane T. Fine structure of hepatic sinusoids and their development in human embryos and fetuses. Acta Pathol Jpn. 1983;33:447–66.

    CAS  PubMed  Google Scholar 

  3. Martinez-Hernandez A, Amenta PS. The hepatic extracellular matrix. II. Ontogenesis, regeneration and cirrhosis. Virchows Arch A Pathol Anat Histopathol. 1993;423:77–84.

    Article  CAS  PubMed  Google Scholar 

  4. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem. 2006;54:385–95.

    Article  CAS  PubMed  Google Scholar 

  5. Neubauer K, Wilfling T, Ritzel A, Ramadori G. Platelet-endothelial cell adhesion molecule-1 gene expression in liver sinusoidal endothelial cells during liver injury and repair. J Hepatol. 2000;32:921–32.

    Article  CAS  PubMed  Google Scholar 

  6. Muro H, Shirasawa H, Kosugi I, Nakamura S. Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis. Am J Pathol. 1993;143:105–20.

    CAS  PubMed  Google Scholar 

  7. Taguchi K, Asano G. Neovascularization of pericellular fibrosis in alcoholic liver disease. Acta Pathol Jpn. 1988;38:615–26.

    CAS  PubMed  Google Scholar 

  8. Hattori M, Fukuda Y, Imoto M, Koyama Y, Nakano I, Urano F. Histochemical properties of vascular and sinusoidal endothelial cells in liver diseases. Gastroenterol Jpn. 1991;26:336–43.

    CAS  PubMed  Google Scholar 

  9. Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M, et al. Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology. 1993;105:475–81.

    CAS  PubMed  Google Scholar 

  10. DeLeve LD. Hepatic microvasculature in liver injury. Semin Liver Dis. 2007;27:390–400.

    Article  CAS  PubMed  Google Scholar 

  11. Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA. Factor VIII expression in liver disease. Thromb Haemost. 2004;91:267–75.

    CAS  PubMed  Google Scholar 

  12. Kelly DA, Tuddenham EG. Haemostatic problems in liver disease. Gut. 1986;27:339–49.

    Article  CAS  PubMed  Google Scholar 

  13. Northup PG, Sundaram V, Fallon MB, Reddy KR, Balogun RA, Sanyal AJ, et al. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost. 2008;6:2–9.

    CAS  PubMed  Google Scholar 

  14. Mouta Carreira C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 2001;61:8079–84.

    CAS  PubMed  Google Scholar 

  15. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144:789–801.

    Article  CAS  PubMed  Google Scholar 

  16. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem. 2001;276:19420–30.

    Article  CAS  PubMed  Google Scholar 

  17. Gale NW, Prevo R, Espinosa J, Ferguson DJ, Dominguez MG, Yancopoulos GD, et al. Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. Mol Cell Biol. 2007;27:595–604.

    Article  CAS  PubMed  Google Scholar 

  18. Kato S, Shimoda H, Ji RC, Miura M. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat Sci Int. 2006;81:71–83.

    Article  PubMed  Google Scholar 

  19. Mäkinen T, Norrmén C, Petrova TV. Molecular mechanisms of lymphatic vascular development. Cell Mol Life Sci. 2007;64:1915–29.

    Article  PubMed  CAS  Google Scholar 

  20. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513–20.

    Article  CAS  PubMed  Google Scholar 

  21. Ikura Y, Ohsawa M, Suekane T, Fukushima H, Itabe H, Jomura H, et al. Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Hepatology. 2006;43:506–14.

    Article  CAS  PubMed  Google Scholar 

  22. Ikura Y, Ohsawa M, Shirai N, Sugama Y, Fukushima H, Suekane T, et al. Expression of angiotensin II type 1 receptor in human cirrhotic livers: its relation to fibrosis and portal hypertension. Hepatol Res. 2005;32:107–16.

    Article  CAS  PubMed  Google Scholar 

  23. Ichida T, Sugitani S, Satoh T, Matsuda Y, Sugiyama M, Yonekura K, et al. Localization of hyaluronan in human liver sinusoids: a histochemical study using hyaluronan-binding protein. Liver. 1996;16:365–71.

    Article  CAS  PubMed  Google Scholar 

  24. Bonder CS, Clark SR, Norman MU, Johnson P, Kubes P. Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere. Blood. 2006;107:4798–806.

    Article  CAS  PubMed  Google Scholar 

  25. Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 2006;20:9–22.

    Article  CAS  PubMed  Google Scholar 

  26. Johnson LA, Prevo R, Clasper S, Jackson DG. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem. 2007;282:33671–80.

    Article  CAS  PubMed  Google Scholar 

  27. Nightingale TD, Frayne ME, Clasper S, Banerji S, Jackson DG. A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium. J Biol Chem. 2009;284:3935–45.

    Article  CAS  PubMed  Google Scholar 

  28. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. J Clin Invest. 1996;98:2403–13.

    Article  CAS  PubMed  Google Scholar 

  29. Noble PW, McKee CM, Cowman M, Shin HS. Hyaluronan fragments activate an NF-kappa B/I-kappa Balpha autoregulatory loop in murine macrophages. J Exp Med. 1996;183:2373–8.

    Article  CAS  PubMed  Google Scholar 

  30. Oka M, Iwata C, Suzuki HI, Kiyono K, Morishita Y, Watabe T, et al. Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood. 2008;111:4571–9.

    Article  CAS  PubMed  Google Scholar 

  31. Tull SP, Anderson SI, Hughan SC, Watson SP, Nash GB, Rainger GE. Cellular pathology of atherosclerosis: smooth muscle cells promote adhesion of platelets to cocultured endothelial cells. Circ Res. 2006;98:98–104.

    Article  CAS  PubMed  Google Scholar 

  32. Urashima S, Tsutsumi M, Nakase K, Wang JS, Takada A. Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol Suppl. 1993;1B:77–84.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Osaka City University Graduate School of Medicine, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8585, Japan

    Junko Arimoto, Yoshihiro Ikura, Takehisa Suekane, Masashi Nakagawa, Chizuko Kitabayashi, Yoko Iwasa & Makiko Ueda

  2. Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, 545-8585, Japan

    Takehisa Suekane & Tetsuo Arakawa

  3. Department of Internal Medicine and Cardiology, Osaka City University Graduate School of Medicine, Osaka, 545-8585, Japan

    Masashi Nakagawa & Kenichi Sugioka

  4. Department of Cardiology, Osaka City General Hospital, Osaka, 534-0021, Japan

    Takahiko Naruko

Authors
  1. Junko Arimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihiro Ikura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takehisa Suekane
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masashi Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chizuko Kitabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoko Iwasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kenichi Sugioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takahiko Naruko
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tetsuo Arakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Makiko Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Makiko Ueda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arimoto, J., Ikura, Y., Suekane, T. et al. Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers. J Gastroenterol 45, 317–325 (2010). https://doi.org/10.1007/s00535-009-0152-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-009-0152-5

Keywords

Search

Navigation